Ceftralin-S 500mg/250mg Injection
Marketer
Medilente Pharma Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Ceftralin-S 500mg/250mg Injection
Ceftralin-S 500mg/250mg injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial growth and propagation. Administration must be strictly under a doctor's guidance; complete the prescribed course, even with symptom improvement, to ensure effectiveness. Premature cessation may compromise treatment efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects necessitate immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, itching, swelling, respiratory distress). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While generally driving ability isn't affected, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a nutritious diet, and proper hydration are crucial for optimal recovery. Your physician might order lab tests to monitor the medicine's impact.
Primary Ingredients of Ceftralin-S 500mg/250mg Injection
No text provided. Please provide the text you would like me to rephrase.
Uses of Ceftralin-S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Ceftralin-S 500mg/250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ceftralin-S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftralin-S 500mg/250mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Ceftralin-S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Ceftralin-S 500mg/250mg Injection, offer a dual antibiotic approach. Ceftriaxone, a key component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam acts as a beta-lactamase inhibitor, bolstering Ceftriaxone's effectiveness by neutralizing bacterial defenses.
SAFETY ADVICE
AlcoholSAFE
Ceftralin-S 500mg/250mg Injection use alongside alcohol consumption presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Ceftralin-S 500mg/250mg injectable solution is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
The administration of Ceftralin-S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Discontinuation of breastfeeding is advised until maternal treatment concludes and the medication is fully cleared from the maternal system.
DrivingUNSAFE
Administering Ceftralin-S 500mg/250mg Injection could induce drowsiness, blurred vision, or dizziness. Driving is inadvisable if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Ceftralin-S 500mg/250mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
The injectable medication, Ceftralin-S 500mg/250mg, requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Ceftralin-S 500mg/250mg Injection is unnecessary for those experiencing mild or moderate liver dysfunction.
What if you forget to take Ceftralin-S 500mg/250mg Injection :
Should you forget a scheduled dose of Ceftralin-S 500mg/250mg Injection, seek advice from your physician.
Facts to Know About Ceftralin-S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently